Paul Rohricht is a life sciences business development expert with nearly $500M in executed transactions. He has founded or co-founded 4 biotech startups, including Revivicor which was acquired by United Therapeutics. He has expertise in early stage technology commercialization for bio/pharma/med devices and startups. His background includes an MS, MBA from UPenn and over 20 years of experience in business development roles.

1. PAUL ROHRICHT MS, MBA
Contacts | Links:
M: +1 704.249.8342; Google Voice: +1 704.765.2110;
E: paul.rohricht.wt02.wharton.upenn.edu
LinkedIn: http://www.linkedin.com/in/paulrohricht
AngelList: https://angel.co/paul-rohricht-ms-mba

2. ABOUT PAUL ROHRICHT MS MBA
• Life Sciences Business Development Expert (in-, out-
licensing, research collaborations, government grants).
• Nearly $500M in executed transactions
• Serial Entrepreneur
• Co-Founder, Revivicor, Inc. (Blacksburg, VA) acq. by
United Therapeutics (RTP, NC).
• Founder, US HQ of Symphogen A/S (Copenhagen,
Denmark). (Note: Symphogen closed the largest venture
round in European Biotech history in 2010, raising € 100M led
by Novo A/S).
• Founder, US HQ of Julabo GmbH.
• 1 Issued US Patent, 4 pending patents (US and EU).
4/7/2016 2

3. PAUL ROHRICHT MS, MBA
• Bio | Pharma | Med Device w/expertise in early stage technology
commercialization
• Startups
• Commercialization Strategy and Execution
• Licensing Strategy and Execution
• Founder or co-founder of 4 biotech startups
• ~$500M in executed business development transactions
• Academic background:
• BA Biology (St. Olaf College, Northfield, MN)
• MS MBA (University of Pennsylvania School of Engineering and
Applied Science and the Wharton School of Business)
4/7/2016 3

4. WORK HISTORY
CONFIDENTIAL 4
• CEO Vedere LLC (biotech business development consultancy)
• COO | Keraplast Technologies, Inc.
• VP Business Development | ICx Technologies, Inc.
• Co-Founder, VP Corporate Development | Revivicor, Inc. (spinout from PPL
Therapeutics, acquired by United Therapeutics)
• VP Business Development | PPL Therapeutics PLC
• Founder, CEO | Technical Marketing Services, Inc.
• Business Development Manager | Creative BioMolecules, Inc.
• National Sales Manager | Verax Corporation (acquired by Creative
Biomolecules)
• National Sales and Marketing Manager | B. Braun Biotech USA
• Sales Representative | Spectra-Physics, Inc.
• Cell Culture Instrumentation Specialist | Endotronics, Inc.
4/7/2016

5. AREAS OF EXPERIENCE: THERAPEUTICS,
DIAGNOSTICS, MEDICAL DEVICES
CONFIDENTIAL 5
• Biologic Therapeutics
• Recombinant antibodies, proteins
• Transgenic proteins
• Diagnostics
• Immunochemistry
• Enzyme immobilization and
stabilization
• POC device, Non-invasive diagnostics
• Medical Devices
• Biological – Cell, Tissue, Proteins
• Recombinant, Transgenic
• Wound Healing
• Polymer-protein Devices,
Controlled release
• Nanotechnology/Nanomedicine
• RNAi
• Cloning (transgenic)
• GLP/cGMP Manufacturing
• Biologics
• Small Molecule
• Fill/Finish
• FDA Regulatory Process
• Large Scale Cell Culture
• Scientific Instrumentation
4/7/2016

6. DEAL SHEET
CONFIDENTIAL 6
• $450M in executed transactions
• Transactions completed world-
wide: US, EU, Japan, Australia,
New Zealand
• In-licensing, out-licensing, JV,
acquisition, spin-out, equity raise
4/7/2016

7. SELECTED TRANSACTION PARTNERS
CONFIDENTIAL 74/7/2016

8. LINKEDIN GROUP FOUNDER
CONFIDENTIAL 8
Circulating
Tumor Cell
(CTC) Group
Cancer Stem Cell
Group
Companion
Diagnostics Group
4/7/2016